RetinaldehydevsVitamin K

Retinaldehyde is converted to retinoic acid by retinaldehyde dehydrogenase (RALDH) in a single enzymatic step within keratinocytes and fibroblasts. This makes it more potent than retinol (which requires alcohol dehydrogenase then RALDH) but less irritating than tretinoin (the active form). The single-step conversion produces a more controlled retinoic acid flux, reducing RAR-mediated irritation while still activating collagen synthesis, normalizing keratinocyte differentiation, and inhibiting matrix metalloproteinases. It uniquely has direct antimicrobial activity against Cutibacterium acnes through disruption of bacterial membrane integrity and interference with bacterial fatty acid metabolism — no other retinoid has this property. Clinically, this dual mechanism addresses both acne pathogenesis and photoaging.

Vitamin K (phytonadione/K1) is cofactor for gamma-glutamyl carboxylase, which carboxylates glutamic acid residues in clotting factors II, VII, IX, X and proteins S, C — essential for calcium binding and coagulation cascade activation. Topically promotes reabsorption of subcutaneous extravasated blood by activating local clotting cascades that convert leaked hemoglobin to biliverdin and bilirubin for clearance. Strengthens capillary walls, reduces vascular permeability. For vascular dark circles: improves vessel wall integrity, reduces hemosiderin deposition. Supports elastic fiber production through matrix Gla protein carboxylation. Has anti-inflammatory effects. Clinical use: bruising, post-procedure ecchymosis, periorbital vascular hyperpigmentation. Results require 4-8 weeks consistent application.